XRTX P/E Ratio
P/E Ratio as of Jul 3, 2025: -3.10
Average-3.06
Median-3.07
Minimum-3.44
Maximum-2.76
-3.10
Past Month+0.11 (3.43%)
The P/E ratio for XRTX is -3.10 as of Jul 3, 2025. This represents a decrease of -73.86% compared to its 12-month average P/E ratio of -11.86. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
XORTX Therapeutics Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
XORTX Therapeutics Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing XORTX Therapeutics Inc. to industry peers.
XORTX Therapeutics Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
XORTX Therapeutics Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing XORTX Therapeutics Inc. to industry peers.
XRTX P/E Ratio Insights
See XORTX Therapeutics Inc.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in XRTX
Order type
Buy in
Order amount
Est. shares
0 shares
XRTX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $0.8923 | -3.07 |
| Jun 2, 2025 | $0.9398 | -3.23 |
| May 1, 2025 | $1.05 | -0.78 |
| Apr 1, 2025 | $0.903 | -0.67 |
| Mar 3, 2025 | $0.941 | -26.21 |
| Feb 3, 2025 | $0.8954 | -24.94 |
| Jan 2, 2025 | $1.1699 | -32.59 |
XRTX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -3.10 | -90.15% |
| 2024 | -31.47 | +5,059.02% |
| 2023 | -0.61 | -112.08% |
| 2022 | 5.05 | -193.00% |
| 2021 | -5.43 | -44.36% |
| 2020 | -9.76 | — |
FAQs About XORTX Therapeutics Inc. (XRTX) P/E ratio
The latest P/E ratio of XRTX is -3.10, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
XORTX Therapeutics Inc.’s last 12-month average P/E ratio is -11.86, compared to its current P/E ratio of -3.10. This reflects a decrease of -73.86%.
XORTX Therapeutics Inc.’s current P/E ratio of -3.10 is lower than its last 12-month average P/E of -11.86. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
XORTX Therapeutics Inc.’s average P/E ratio over the last 3 years is -4.52. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
XORTX Therapeutics Inc.’s average P/E ratio over the last 5 years is -5.86. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.